The 2 ‘ 3 ‘ -cGAMP analogue, c-di-AMP, activates the STING pathway to induce apoptosis in estrogen receptor-negative breast cancer cells, resulting in the release of tumor antigens (TAs) and propagation of the cancer-immunity cycle (30). The gene discussed is STING1; the disease is neoplasm.